Litigation Details for AstraZeneca AB v. Mylan Pharmaceuticals Inc. (D. Del. 2018)
✉ Email this page to a colleague
AstraZeneca AB v. Mylan Pharmaceuticals Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-10-11 |
| Court | District Court, D. Delaware | Date Terminated | 2019-11-04 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Parties | MYLAN LABORATORIES LIMITED | ||
| Patents | 10,166,247; 7,759,328; 7,967,011; 8,143,239; 8,575,137 | ||
| Attorneys | Anna Q. Han | ||
| Firms | Perkins Coie LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AstraZeneca AB v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AstraZeneca AB v. Mylan Pharmaceuticals Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-10-18 | 156 | Opinion - Memorandum Opinion | additional patent to the lawsuit, United States Patent No. 10,166,247 (the "#247 patent"). See…quot;#239 patent"), 8,575,137 (the "#137 patent"), and 7,967,011 (the #011 patent").…of infringing United States Patent Nos. 7,759,328 (the "#328 patent"), 8,143,239 (the 1 …Pharmaceuticals Inc. ("Mylan") and 3M Company for patent infringement. Before me is Mylan's motion …Paragraph IV certifications against the asserted patents. D.I. 41, Ex. B. On August 15, 2018, the FDA sent | External link to document |
| 2019-01-06 | 20 | of U.S. Patent Nos. 7,759,328, 8,143,239, 8,575,137, and 7,967,011 (collectively, the “patents-in-suit…....... 5 B. Venue in Patent Infringement Actions ..........................…..................6 In re Rosuvastatin Calcium Patent Litig., 719 F. Supp. 2d 388 (D. Del. 2010) …INTRODUCTION AND SUMMARY OF ARGUMENT This patent infringement action arises from the filing of ANDA…that these entities will infringe Plaintiffs’ patents in the future. But MLL, Mylan Inc., and Mylan N.V | External link to document | |
| 2018-10-11 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328; 8,143,239; 8,575,137…2018 4 November 2019 1:18-cv-01562 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
